- PA 824
-
PA 824 (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazineIdentifiers CAS number 187235-37-6 PubChem 456199 MeSH PA+824 ChEMBL CHEMBL227875 Jmol-3D images Image 1 - [O-][N+](=O)c1cn2C[C@@H](COc2n1)OCc3ccc(OC(F)(F)F)cc3
Properties Molecular formula C14H12F3N3O5 Molar mass 359.258 g/mol 824 (verify) (what is: / ?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)Infobox references PA 824 is an experimental anti-tuberculosis drug.[1][2]
References
- ^ Ginsberg AM, Laurenzi MW, Rouse DJ, Whitney KD, Spigelman MK (September 2009). "Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects". Antimicrob. Agents Chemother. 53 (9): 3720–5. doi:10.1128/AAC.00106-09. PMC 2737845. PMID 19528280. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=19528280.
- ^ Stover CK, Warrener P, VanDevanter DR, et al (2000). "A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis". Nature 405 (6789): 962–6. doi:10.1038/35016103. PMID 10879539.
See also
This antiinfective drug article is a stub. You can help Wikipedia by expanding it.